Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Hepato-Biliary-Pancreatic Sciences
Published in: Journal of Hepato-Biliary-Pancreatic Sciences 1/2013

01-01-2013 | Guideline

TG13 management bundles for acute cholangitis and cholecystitis

Authors: Kohji Okamoto, Tadahiro Takada, Steven M. Strasberg, Joseph S. Solomkin, Henry A. Pitt, O. James Garden, Markus W. Büchler, Masahiro Yoshida, Fumihiko Miura, Yasutoshi Kimura, Ryota Higuchi, Yuichi Yamashita, Toshihiko Mayumi, Harumi Gomi, Shinya Kusachi, Seiki Kiriyama, Masamichi Yokoe, Wan-Yee Lau, Myung-Hwan Kim

Published in: Journal of Hepato-Biliary-Pancreatic Sciences | Issue 1/2013

Login to get access

Abstract

Bundles that define mandatory items or procedures to be performed in clinical practice have been increasingly used in guidelines in recent years. Observance of bundles enables improvement of the prognosis of target diseases as well as guideline preparation. There were no bundles adopted in the Tokyo Guidelines 2007, but the updated Tokyo Guidelines 2013 (TG13) have adopted this useful tool. Items or procedures strongly recommended in clinical practice have been prepared in the practical guidelines and presented as management bundles. TG13 defined the mandatory items for the management of acute cholangitis and acute cholecystitis. Critical parts of the bundles in TG13 include diagnostic process, severity assessment, transfer of patients if necessary, therapeutic approach, and time course. Their observance should improve the prognosis of acute cholangitis and cholecystitis. When utilizing TG13 management bundles, further clinical research needs to be conducted to evaluate the effectiveness and outcomes of the bundles. It is also expected that the present report will lead to evidence construction and contribute to further updating of the Tokyo Guidelines.
Free full-text articles and a mobile application of TG13 are available via http://​www.​jshbps.​jp/​en/​guideline/​tg13.​html.
Literature
1.
Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Crit Care Med. 2008;36:296–327.PubMedCrossRef
2.
Daniels R, Nutbeam T, McNamara G, Galvin C. The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study. Emerg Med J. 2011;28:507–12.PubMedCrossRef
3.
Benneyan JC, Taseli A. Exact and approximate probability distributions of evidence-based bundle composite compliance measures. Health Care Manag Sci. 2010;13:193–209.PubMedCrossRef
4.
Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med. 2010;36:222–31.PubMedCrossRef
5.
Murata A, Matsuda S, Kuwabara K, Fujino Y, Kubo T, Fujimori K, et al. Evaluation of compliance with the Tokyo Guidelines for the management of acute cholangitis based on the Japanese administrative database associated with the Diagnosis Procedure Combination system. J Hepatobiliary Pancreat Sci. 2011;18:53–9.PubMedCrossRef
6.
Murata A, Matsuda S, Kuwabara K, Fujino Y, Kubo T, Fujimori K, et al. An observational study using a national administrative database to determine the impact of hospital volume on compliance with clinical practice guidelines. Med Care. 2011;49:313–20.PubMedCrossRef
7.
Gao F, Melody T, Daniels DF, Giles S, Fox S. The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care. 2005;9:R764–70.PubMedCrossRef
8.
Nguyen HB, Corbett SW, Steele R, Banta J, Clark RT, Hayes SR, et al. Implementation of a bundle of quality indicators for the early management of severe sepsis and septic shock is associated with decreased mortality. Crit Care Med. 2007;35:1012–105.CrossRef
9.
Ferrer R, Artigas A, Levy MM, Blanco J, González-Díaz G, Garnacho-Montero J, et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA. 2008;299:2294–303.PubMedCrossRef
10.
Galpern D, Guerrero A, Tu A, Fahoum B, Wise L. Effectiveness of a central line bundle campaign on line-associated infections in the intensive care unit. Surgery. 2008;144:492–5.PubMedCrossRef
11.
Berriel-Cass D, Adkins FW, Jones P, Fakih MG. Eliminating nosocomial infections at Ascension Health. Jt Comm J Qual Patient Saf. 2006;32:612–20.PubMed
12.
Crocker C, Kinnear W. Weaning from ventilation: does a care bundle approach work? Intensive Crit Care Nurs. 2008;24:180–6.PubMedCrossRef
13.
De Miguel-Yanes JM, Andueza-Lillo JA, Gonzalez-Ramallo VJ, Pastor L, Muñoz J. Failure to implement evidence-based clinical guidelines for sepsis at the ED. Am J Emerg Med. 2006;24:553–9.PubMedCrossRef
14.
McNeill G, Dixon M, Jenkins P. Can acute medicine units in the UK comply with the Surviving Sepsis Campaign’s six-hour care bundle? Clin Med. 2008;8:163–5.PubMed
15.
Mayumi T, Takada T, Hirata K, Yoshida M, Sekimoto M, Hirota M, et al. Pancreatitis bundles. J Hepatobiliary Pancreat Sci. 2010;17:87–9.PubMedCrossRef
16.
Kiriyama S, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Pitt HA, et al. New diagnostic criteria and severity assessment of acute cholangitis in revised Tokyo guidelines. J Hepatobiliary Pancreat Sci. 2012;19:548–56.PubMedCrossRef
17.
Yokoe M, Takada T, Strasberg SM, Solomkin JS, Mayumi T, Gomi H, et al. New diagnostic criteria and severity assessment of acute cholecystitis in revised Tokyo guidelines. J Hepatobiliary Pancreat Sci. 2012;19:578–85.PubMedCrossRef
Metadata
Title
TG13 management bundles for acute cholangitis and cholecystitis
Authors
Kohji Okamoto
Tadahiro Takada
Steven M. Strasberg
Joseph S. Solomkin
Henry A. Pitt
O. James Garden
Markus W. Büchler
Masahiro Yoshida
Fumihiko Miura
Yasutoshi Kimura
Ryota Higuchi
Yuichi Yamashita
Toshihiko Mayumi
Harumi Gomi
Shinya Kusachi
Seiki Kiriyama
Masamichi Yokoe
Wan-Yee Lau
Myung-Hwan Kim
Publication date
01-01-2013
Publisher
Springer Japan
Published in
Journal of Hepato-Biliary-Pancreatic Sciences / Issue 1/2013
Print ISSN: 1868-6974
Electronic ISSN: 1868-6982
DOI
https://doi.org/10.1007/s00534-012-0562-2

Other articles of this Issue 1/2013

Journal of Hepato-Biliary-Pancreatic Sciences 1/2013 Go to the issue

Announcement

Newsletter, January 1, 2013

Guideline

TG13 flowchart for the management of acute cholangitis and cholecystitis

Guideline

TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis

Guideline

TG13 indications and techniques for biliary drainage in acute cholangitis (with videos)

Guideline

TG13 surgical management of acute cholecystitis

Guideline

TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis